Support is requested for a Keystone Symposia meeting entitled Stem Cells and Cancer, organized by Austin Gurney, Connie J. Eaves and Jane E. Visvader. The meeting will be held in Breckenridge, Colorado from March 6-11, 2016. Cancer stem cells have now been recognized in a wide variety of human tumors. The existence of cancer stem cells poses both tremendous challenges and tantalizing potential for our ability to successfully combat cancer. This meeting aims to bring together scientists who are interested in better understanding the mechanisms by which cancer stem cells contribute to tumor heterogeneity, self-renewal and drug resistance. One area of emphasis will be intercellular communication. Cellular context and microenvironment establish the tumor niche and shape the interaction of the tumor with the immune system. In addition, developmental signal transduction pathways such as Hippo, Notch and Wnt, frequently deregulated in cancer, increasingly offer tangible opportunities for therapeutic intervention. Another important area of emphasis will be efforts to better understand the mechanisms and importance of tumor heterogeneity. Techniques such as clonal analysis and barcoding are shedding important light on the interplay between tumor evolution, differentiation, miRNA control and epigenetics. This is an era of rapid progress in understanding cancer stem cell biology with great potential to benefit human health, and it is a topic of clear relevance to the mission of the National Cancer Institute.

Public Health Relevance

Cancer remains the second leading cause of death in the United States and a leading cause of mortality worldwide. Despite intensive research, effective treatment for most types of metastatic tumor remains elusive. The Keystone Symposia meeting on Stem Cells and Cancer aims to bring together researchers focused on stem cell biology, tumor heterogeneity, and pharmaceutical development to exchange perspectives, to better understand the nature of the challenge that cancer stem cells present, and to foster new therapeutic progress.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Conference (R13)
Project #
1R13CA200143-01
Application #
8985625
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Turner, Michelle C
Project Start
2016-03-01
Project End
2016-11-15
Budget Start
2016-03-01
Budget End
2016-11-15
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Keystone Symposia
Department
Type
DUNS #
079780750
City
Silverthorne
State
CO
Country
United States
Zip Code
80498